The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development.
暂无分享,去创建一个
[1] B. Fleischmann,et al. The use of quantitative image analysis in the assessment of in vitro embryotoxicity endpoints based on a novel embryonic stem cell clone with endoderm-related GFP expression. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.
[2] C. Foster,et al. Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases. , 2003, Current pharmaceutical design.
[3] S. Bremer,et al. Detection of the Embryotoxic Potential of Cyclophosphamide by Using a Combined System of Metabolic Competent Cells and Embryonic Stem Cells , 2002, Alternatives to laboratory animals : ATLA.
[4] M. Harada,et al. Congenital Minamata disease: intrauterine methylmercury poisoning. , 1978, Teratology.
[5] G. Lyons,et al. Embryonic stem cells and in vitro muscle development. , 1996, Current topics in developmental biology.
[6] Y. Capetanaki,et al. Cytoskeletal control of myogenesis: a desmin null mutation blocks the myogenic pathway during embryonic stem cell differentiation. , 1995, Developmental biology.
[7] N. Z. Zur Nieden,et al. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. , 2003, Differentiation; research in biological diversity.
[8] L. Holmes,et al. Malformations due to presumed spontaneous mutations in newborn infants. , 1989, The New England journal of medicine.
[9] Richard T. Lee,et al. Ascorbic Acid Enhances Differentiation of Embryonic Stem Cells Into Cardiac Myocytes , 2003, Circulation.
[10] M. Lako,et al. mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells , 2000, Mechanisms of Development.
[11] P. Fort,et al. A fluorescent reporter gene as a marker for ventricular specification in ES‐derived cardiac cells , 2000, FEBS letters.
[12] A. Seiler,et al. [Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)]. , 2002, ALTEX.
[13] W. Lenz. Malformations caused by drugs in pregnancy. , 1966, American journal of diseases of children.
[14] M. Schuldiner,et al. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells , 2001, Current Biology.
[15] L. Holmes. Impact of the detection and prevention of developmental abnormalities in human studies. , 1997, Reproductive toxicology.
[16] H. Grabsch,et al. Temporospatial Relationships between Macroglia and Microglia during in vitro Differentiation of Murine Stem Cells , 1998, Developmental Neuroscience.
[17] C. Dehay,et al. In vitro differentiation of embryonic stem cells into glial cells and functional neurons. , 1995, Journal of cell science.
[18] Elke Genschow,et al. Embryotoxicity Screening Using Embryonic Stem Cells in vitro: Correlation to in vivo Teratogenicity , 1999, Cells Tissues Organs.
[19] J. J. Amy,et al. Methods in prenatal toxicology , 1979 .
[20] N A Brown,et al. Teratogenicity testing in vitro: status of validation studies. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.
[21] M. Segal,et al. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro , 1996, Mechanisms of Development.
[22] H. Spielmann,et al. Reproduction and development. , 1998, Environmental health perspectives.
[23] Wilson Jg. Teratogenic effects of environmental chemicals. , 1977 .
[24] C. Dani. Embryonic Stem Cell-Derived Adipogenesis , 1999, Cells Tissues Organs.
[25] M. Rudnicki,et al. Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells. , 1990, Developmental biology.
[26] R. Fässler,et al. Differentiation and integrity of cardiac muscle cells are impaired in the absence of beta 1 integrin. , 1996, Journal of cell science.
[27] A M Wobus,et al. Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies: present state and future prospects. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[28] S. Bremer,et al. Development of an in vitro embryotoxicity test using murine embryonic stem cell cultures. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.
[29] B. Fleischmann,et al. Quantitation and functional characterization of neural cells derived from ES cells using nestin enhancer-mediated targeting in vitro. , 2002, Journal of cell science.
[30] B. Fleischmann,et al. Differential Role of bFGF and VEGF for Vasculogenesis , 2002, Cellular Physiology and Biochemistry.
[31] L. Samuelson,et al. Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro. , 1996, Circulation research.
[32] K. Ishikawa. Heme oxygenase-1 against vascular insufficiency: roles of atherosclerotic disorders. , 2003, Current pharmaceutical design.
[33] M. Darmon,et al. Control by the extracellular environment of differentiation pathways in 1003 embryonal carcinoma cells: study at the level of specific intermediate filaments. , 1982, The EMBO journal.
[34] Jürgen Hescheler,et al. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types , 1993, Mechanisms of Development.
[35] Janet Rossant,et al. Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity. , 2002, Genome research.
[36] Peter J. Donovan,et al. Derivation of pluripotent stem cells from cultured human primordial germ cells , 1998 .
[37] V. Maltsev,et al. In vitro differentiation of embryonic stem cells into cardiomyocytes or skeletal muscle cells is specifically modulated by retinoic acid , 2004, Roux's archives of developmental biology.
[38] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[39] K. Damus,et al. An overview of infant mortality and birth defects in the United States. , 1997, Teratology.
[40] N. Brown. Selection of Test Chemicals for the ECVAM International Validation Study on In Vitro Embryotoxicity Tests , 2002, Alternatives to laboratory animals : ATLA.
[41] B. Fleischmann,et al. Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[42] L. Samuelson,et al. Troponin I isoform expression is developmentally regulated in differentiating embryonic stem cell‐derived cardiac myocytes , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.
[43] A. Piersma,et al. [Results of the first phase of the ECVAM project "prevalidation and validation of three in vitro embryotoxicity tests"] , 1998, ALTEX.
[44] Chun Han,et al. Macroscopic cartilage formation with embryonic stem-cell-derived mesodermal progenitor cells , 2003, Journal of Cell Science.
[45] W. Horton,et al. Whole embryo culture: a screening technique for teratogens? , 1982, Teratogenesis, carcinogenesis, and mutagenesis.
[46] D. Fürst,et al. Modulation of sarcomere organization during embryonic stem cell-derived cardiomyocyte differentiation. , 1999, European journal of cell biology.
[47] F. Tang,et al. Rapid Communication: Differentiation of Embryonic Stem Cell to Astrocytes Visualized by Green Fluorescent Protein , 2002, Cellular and Molecular Neurobiology.
[48] H. Spielmann,et al. Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. , 1991, Reproductive toxicology.
[49] P. Brûlet,et al. Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. , 1981, Journal of embryology and experimental morphology.
[50] A. Rizzino,et al. DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells , 2000, Molecular reproduction and development.
[51] B. Fleischmann,et al. Functional Characteristics of ES Cell–derived Cardiac Precursor Cells Identified by Tissue-specific Expression of the Green Fluorescent Protein , 1998, The Journal of cell biology.
[52] O. Flint,et al. In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test. , 1993, Reproductive toxicology.
[53] F. Watt,et al. Differentiation of embryonal stem cells into keratinocytes: comparison of wild-type and beta 1 integrin-deficient cells. , 1996, Developmental biology.
[54] K. Miura,et al. Quantitative assessment of DNA microarrays--comparison with Northern blot analyses. , 2001, Genomics.
[55] Aldert Piersma,et al. The ECVAM International Validation Study on In Vitro Embryotoxicity Tests: Results of the Definitive Phase and Evaluation of Prediction Models , 2002, Alternatives to laboratory animals : ATLA.
[56] D. Fischman,et al. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro , 1982, The Journal of cell biology.
[57] K. Beedles,et al. The stem-cell test-A novel in vitro assay for teratogenic potential. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.
[58] G. Kimmel,et al. Overview of In Vitro Teratogenicity Testing: aspects of validation and application to screening. , 1982, Teratogenesis, carcinogenesis, and mutagenesis.
[59] D. Solter,et al. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[60] H. Spielmann,et al. The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines : 3T3 fibroblasts and embryonic stem cells , 1997 .
[61] V. Kríz,et al. The SHB adapter protein is required for efficient multilineage differentiation of mouse embryonic stem cells. , 2003, Experimental cell research.
[62] E. Kurowska. Nitric oxide therapies in vascular diseases. , 2002, Current pharmaceutical design.
[63] H. Rindt,et al. Distant upstream regulatory domains direct high levels of beta -myosin heavy chain gene expression in differentiated embryonic stem cells. , 2000, Journal of molecular and cellular cardiology.
[64] N. Cohen-Addad,et al. Factors relating to readmission of term and near term neonates in the first two weeks of life , 1999, Journal of perinatal medicine.
[65] J. Bantle,et al. Developmental toxicity testing with FETAX: evaluation of five compounds. , 1989, Drug and chemical toxicology.
[66] T. Era,et al. Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system. , 2000, Blood.
[67] Horst Spielmann,et al. Screening Chemicals for Reproductive Toxicity: The Current Alternatives , 1995 .
[68] C. Andressen,et al. Cardiac specific expression of the green fluorescent protein during early murine embryonic development , 1998, FEBS letters.
[69] W. Mcbride,et al. Thalidomide and Congenital Abnormalities , 1961 .
[70] N. Z. Zur Nieden,et al. Molecular markers in embryonic stem cells. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[71] P. Doevendans,et al. Differentiation of cardiomyocytes in floating embryoid bodies is comparable to fetal cardiomyocytes. , 2000, Journal of molecular and cellular cardiology.